- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04286646
Correlation of Pupillary Diameter Changewith Age and Anterior Chamber Depth After Cataract Surgery
Correlation of Pupillary Diameter Change With Age and Anterior Chamber Depth After Cataract Surgery
Study Overview
Status
Conditions
Detailed Description
Healthy patients who are going to be operated on for cataracts are expected to take part in the study. If during the clinical study the minimum number of patients established in the protocol is exceeded, new samples will continue to be registered until the end of the established period.
The sample selection mechanism is by consecutive recruitment during the study period (in order of arrival at the medical office). Patients are operated bilaterally in a period not exceeding 15 days and it will get the variables of both eyes. A simple random sampling will be used for the choice of single eye data per patient.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Barcelona, Spain, 08022
- Clinica Oftalmológica TACIR
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Both sexes with age equal to or greater than 45 years
- Diagnosed cataract N1, C1, P1 or worse in some eye.
- Patients who will be operated on both eyes.
- Patients who have not been diagnosed with diabetes mellitus.
- Patients who have given their informed consent to take part in the study.
Exclusion Criteria:
- Age under 45 years.
- Patients with anisocoria, neurological disorders, diagnosed with diabetes mellitus, glaucoma or another eye disease.
- Patients with complications during and after cataract surgery.
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Pupil diameter before/after cataract
The investigators measure the pupil diameter before and after (3 months) cataract.
Mesopic and photopic conditions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pupil diameter
Time Frame: Preoperatively and 3-months postoperatively
|
It took measurements of pupil diameter in mesopic and photopic conditions using pupillometer software of the Topolyzer Vario (Wavelight Laser Technologie AG).
|
Preoperatively and 3-months postoperatively
|
|
Anterior Chamber Depht
Time Frame: Preoperatively
|
Anterior chamber depth was obtained with Pentacam® (Oculus Optikgeräte GmbH, Wetzlar, Germany).
|
Preoperatively
|
|
Age
Time Frame: Preoperatively
|
It took the patient's age at the time of surgery
|
Preoperatively
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Enrique Ordiñaga-Monreal, OD, Clinica Oftalmológica TACIR
Publications and helpful links
General Publications
- Kanellopoulos AJ, Asimellis G, Georgiadou S. Digital pupillometry and centroid shift changes after cataract surgery. J Cataract Refract Surg. 2015 Feb;41(2):408-14. doi: 10.1016/j.jcrs.2014.05.049.
- Ordinaga-Monreal E, Castanera-Gratacos D, Castanera F, Fambuena-Muedra I, Vega F, Millan MS. Pupil size differences between female and male patients after cataract surgery. J Optom. 2022 Apr-Jun;15(2):179-185. doi: 10.1016/j.optom.2020.09.005. Epub 2021 Feb 3.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EC022018
- 47/2018 (Other Identifier: CEIm Grupo Hospitalario Quirónsalud-Catalunya)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pupillary Disorders
-
NYU Langone HealthCompleted
-
Medical University of ViennaRecruitingPupillary Reflex ImpairedAustria
-
University of Texas Southwestern Medical CenterCompletedInterrater Reliability Among Pupillary Assessments
-
Taejoon Pharmaceutical Co., Ltd.RecruitingPupillary Dilation Effect During Cycloplegic RefractionKorea, Republic of
-
Seoul National University HospitalUnknownPupillary Functions, AbnormalKorea, Republic of
-
University Hospital, AntwerpCompleted
-
RWTH Aachen UniversityUnknownCerebral Aneurysm | Pupillary Function, AbnormalGermany
-
Daegu Catholic University Medical CenterCompletedAnesthesia, General | Cholecystectomy, Laparoscopic | Reflex, PupillaryKorea, Republic of
-
National University of SingaporeHome Team Science & Technology Agency (HTX)RecruitingCaffeine | Physiological Responses | Optical Coherence Tomography | Pupillary Response | Alcohol | Optical Coherence Tomography Angiography | Eye MovementsSingapore
-
University Hospital, AntwerpCompletedCritical IllnessBelgium